Authors:
Grimm, RH
Margolis, KL
Papademetriou, V
Cushman, WC
Ford, CE
Bettencourt, J
Alderman, MH
Basile, JN
Black, HR
DeQuattro, V
Eckfeldt, J
Hawkins, CM
Perry, HM
Proschan, M
Citation: Rh. Grimm et al., Baseline characteristics of participants in the Antihypertensive and LipidLowering Treatment to Prevent Heart Attack Trial (ALLHAT), HYPERTENSIO, 37(1), 2001, pp. 19-27
Authors:
Furberg, CD
Wright, JT
Davis, BR
Cutler, JA
Alderman, M
Black, H
Cushman, W
Grimm, R
Haywood, LJ
Leenen, F
Oparil, S
Perry, HM
Probstfield, J
Whelton, P
Payne, G
Nwachuku, C
Gordon, D
Proschan, M
Frommer, P
Einhorn, P
Hawkins, M
Ford, C
Pressel, S
Piller, L
Lusk, C
Bettencourt, J
Kimmel, B
Geraci, T
Walsh, S
Rahman, M
Juratovac, A
Pospisil, R
Brennan, K
Carroll, L
Sullivan, S
Barone, G
Christian, R
Feldman, S
Lucente, T
Lewis, CE
Jenkins, K
McDowell, P
Johnson, J
Kingry, C
Letterer, R
Margolis, K
Holland, L
Jaeger-Fox, B
Williamson, J
Louis, G
Ragusa, P
Williard, A
Ferguson, RS
Tanner, J
Eckfeldt, J
Crow, R
Pelosi, J
Citation: Cd. Furberg et al., Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone - The Antihypertensive and Lipid-Lowering Treatment toPrevent Heart Attack Trial (ALLHAT), J AM MED A, 283(15), 2000, pp. 1967-1975